Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05107765 · ClinicalTrials.gov registry record · Phase 1
Effects of Pioglitazone on Stress Reactivity and Alcohol Craving
A Phase 1 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 1
- Development phase
- 67
- Enrollment target
NCT05107765 is a Phase 1 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 67 participants.
The verdict
NCT05107765, a Phase 1 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 67 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effects of pioglitazone on stress-induced relapse risk in a laboratory model and to examine the effects of pioglitazone on drinking, stress/anxiety, and alcohol craving in the natural environment
Interventions
- DRUG Placebo
- DRUG Pioglitazone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2022-05-12 |
| Est. Completion | 2024-08-16 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05107765
The ClinicalTrials.gov registry entry for NCT05107765 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05107765 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05107765 about?
NCT05107765 is a clinical study titled "Effects of Pioglitazone on Stress Reactivity and Alcohol Craving". The purpose of this study is to examine the effects of pioglitazone on stress-induced relapse risk in a laboratory model and to examine the effects of pioglitazone on drinking, stress/anxiety, and alcohol craving in the natural environment
What is the current status of trial NCT05107765?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 67 participants. The study started on 2022-05-12. Estimated completion is 2024-08-16.
What interventions are being tested in trial NCT05107765?
The interventions under investigation include: Placebo (DRUG), Pioglitazone (DRUG).
Who is sponsoring clinical trial NCT05107765?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.